Brief: Labcorp To Spin Off Clinical-Development Business - WSJ
July 28 (Reuters) -
* LABCORP TO SPIN OFF CLINICAL-DEVELOPMENT BUSINESS - WSJ
* LABCORP'S BUSINESSES THAT IS BEING SPUN OFF GENERATED
REVENUE OF
ROUGHLY $3 BILLION IN 12 MONTHS ENDED IN JUNE - WSJ
Source text: https://on.wsj.com/3PWzjKB
Further company coverage: LH.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laboratory of America Holdings
See all newsBrief: Labcorp To Announce Second Quarter 2026 Financial Results On July 30, 2026
Brief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health